Integrated Therapeutic Approaches in the Treatment of Female Androgenetic Alopecia: A Case Report

Abstract

Introduction: Female Androgenetic Alopecia (FAA) is a clinical condition characterized by hair loss, primarily due to the action of androgens, which leads to the progressive miniaturization of hair follicles. The pathophysiology of FAA is multifactorial, with genetic and hormonal factors playing crucial roles, although the disease can develop even without significant elevations in androgen levels. The traditional treatment for female androgenetic alopecia includes the use of minoxidil, which has been shown to be effective in preventing disease progression. However, treatment should be personalized, considering the patient's history and clinical condition. This case study aimed to evaluate the effectiveness of a multimodal treatment for FAA, combining topical, oral therapies, and active ingredient microinfusion.

Case Report: The treated patient showed significant results, with continuous hair growth, improvement in hair density, and no observed hair loss. The multimodal treatment, which included the use of minoxidil, baicapil, capilia longa, actrisave, chelated zinc, and saw palmetto, in addition to microinfusion with KGF, copper peptide, and trichoxidil, was effective in stabilizing the condition and promoting hair growth, proving to be an efficient and sustainable alternative.

Conclusion: The personalized approach, considering the clinical characteristics of the patient, as well as the combination of different treatment modalities, may provide more effective and long-lasting results for patients with FAA. However, further studies are needed to validate the efficacy of combined therapies and the long-term psychological impact of the treatment.